|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$48,000
|
N/A
|
National Cancer Institute
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
|
5R01CA201247-03
|
$511,614
|
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
AFRICAN FEMALE BREAST CANCER EPIDERMIOLOGY (AFBRECANE) STUDY
|
5U01HG009784-02
|
$85,000
|
|
ADEBAMOWO, CLEMENT
|
INSTITUTE OF HUMAN VIROLOGY
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Novel Combinatorial Therapeutic Approach for Prostate Cancer
|
5R03CA219336-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-05
|
$382,616
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
5R50CA211533-03
|
$122,475
|
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women
|
5K01TW010271-03
|
$134,531
|
|
AKINYEMIJU, TOMI
|
UNIVERSITY OF KENTUCKY
|
|
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
|
1R43CA228721-01
|
$299,607
|
|
AKPORIAYE, EMMANUEL
|
VEANA THERAPEUTICS, LLC
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy
|
1R43CA221490-01A1
|
$300,000
|
|
ALEXANIAN, ARSHAK
|
CELL REPROGRAMMING AND THERAPEUTICS, LLC
|
|
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
|
2R44CA192428-02A1
|
$893,847
|
|
ALLEN, MICHAEL
|
EMBOLX, INC.
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-41S2
|
$99,294
|
$3,972
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-41
|
$2,527,733
|
$101,109
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
|
5U01CA196386-05
|
$895,779
|
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Characterization of the gammaherpes virus specific tegument protein, pORF52, in t
|
1F31CA159451-01
|
$28,163
|
$28,163
|
Anderson, Melissa
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Steroid hormone regulation of immune responses
|
1R01CA229400-01
|
$384,018
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
Predictive signatures in breast cancer using multiplexed ion beam imaging
|
5DP5OD019822-05
|
$401,249
|
|
ANGELO, ROBERT
|
STANFORD UNIVERSITY
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
ZIA BC 009101
|
$135,643
|
$67,821
|
Appella, Ettore
|
CCR (NCI)
|
|
Clinical Validation of the Multiple Biopsy Device, a Novel Endoscopic Biopsy Technology
|
1R43CA228656-01
|
$206,274
|
|
APPLING, ANTHONY
|
ENDOSCOPIC ASSIST DEVICES, LLC
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-10
|
$491,462
|
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
Mixed-Methods approach to evaluate a mHealth intervention to increase adherence to triage of HPV+ women who have performed self-collection
|
5R01CA218306-02
|
$393,216
|
|
ARROSSI, SILVINA
|
CENTER FOR THE STUDY OF STATE / SOCIETY
|
|
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
|
1R01CA230516-01
|
$564,655
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-05
|
$620,114
|
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of Mitochondrial Respiratory Stress Signaling in Cancer Progression
|
5R01CA022762-30
|
$340,007
|
$340,007
|
AVADHANI, NARAYAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$99,147
|
$2,974
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$297,441
|
$2,974
|
Avital, Itzhak
|
CCR (NCI)
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
7U01CA066531-15
|
$716,105
|
$143,221
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
$631,958
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
|
5U01CA217846-02
|
$974,850
|
|
BADER, JOEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-06
|
$119,402
|
$119,402
|
BAGATELL, ROCHELLE
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
MammoCAT Advanced Full Field Digital Mammography System
|
1R43CA224851-01A1
|
$299,950
|
|
BAMBOT, SHABBIR
|
FISCHER IMAGING, INC.
|
|
Disparities in the Availability of Cancer Clinical Trials: A Multi-level Analysis
|
5R03CA219621-02
|
$77,750
|
|
BANSAL, AASTHAA
|
UNIVERSITY OF WASHINGTON
|
|
Host Defense Regulation and Viral Oncogenesis
|
5P01CA128115-02
|
$1,166,688
|
$105,002
|
Barber, Glen
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
DNA methylation-based assays for detecting disease spread in rhabdomyosarcoma
|
1R21CA150091-01
|
$174,000
|
$174,000
|
BARR, FREDERIC
|
UNIVERSITY OF PENNSYLVANIA
|
Total relevant funding to Sarcoma for this search: $70,635,122
|